Healthcare Equipment and Supplies
Company Overview of Banyan Biomarkers, Inc.
Banyan Biomarkers, Inc. researches and develops in vitro diagnostic products to detect traumatic brain injuries (TBIs). The company offers biomarkers for traumatic brain injuries and strokes, psychiatric disorders, neuroinflammation/microglial activation, apoptosis, necrosis, and liver injuries/hepatoxicity; biomarkers for stroke, Alzheimer’s disease, Parkinson’s and Huntington’s disease, and depression; and therapeutic candidates for neuro-protection. It also develops sandwich-enzyme linked immunosorbent assays in cerebro-spinal fluid, plasma, and serum for various neurological, neurodegenerative, and neuropsychiatric diseases. In addition, the company offers preclinical and clinical sample...
13400 Progress Boulevard
Alachua, FL 32615
Founded in 2002
Key Executives for Banyan Biomarkers, Inc.
Director of Corporate Operations
Compensation as of Fiscal Year 2014.
Banyan Biomarkers, Inc. Key Developments
Banyan Biomarkers, Inc. Presents at Latin America & Caribbean Life Sciences Conference, Mar-28-2014 10:45 AM
Mar 24 14
Banyan Biomarkers, Inc. Presents at Latin America & Caribbean Life Sciences Conference, Mar-28-2014 10:45 AM. Venue: Graham Center Ballroom, FIU-Maidique Campus, Miami, Florida, United States. Speakers: Luis De Taboada, Vice President of Engineering.
Banyan Biomarkers, Inc. Presents at Southeast BIO Investor & Partnering Forum, Nov-06-2013 02:05 PM
Nov 1 13
Banyan Biomarkers, Inc. Presents at Southeast BIO Investor & Partnering Forum, Nov-06-2013 02:05 PM. Venue: Jefferson Hotel, Richmond, Virginia, United States.
Banyan Biomarkers, Inc. Wins $12,950,816 Cost-Plus-Fixed-Fee, Non-Option-Eligible, Multi-Year Contract
Sep 23 13
Banyan Biomarkers Inc. was awarded a $12,950,816 cost-plus-fixed-fee, non-option-eligible, multi-year contract modification (P00015) of contract (W81XWH-10-C-0251) for a within scope increase to develop a mild/moderate traumatic brain injury assay for use on the Johnson & Johnson/Ortho Clinical Diagnostics VITROs (r) MicroWell device to analyze clinical trial samples. Performance locations will be Rochester, N.Y., Alachua, Fla., and Carlsbad, Calif., with funding from fiscal 2012 and 2013 research development testing and evaluation funds. This contract was a non- competitive acquisition with one bid received. The U.S. Army Medical Research Acquisition Activity, Frederick, Md., is the contracting activity.
Similar Private Companies By Industry
Recent Private Companies Transactions
December 3, 2013